Flu 2026: Biosecurity Strategies for the Winter Peak
In the current period, in the midst of the flu season, our country is preparing for the peak of infections, undergoing a rather intense epidemic trend. The 2025-2026 season, in fact, has proven to be quite problematic, impacting collective well-being and the capacity of the national health system.
In the following paragraphs, we will look at current data from the epidemic season, focusing on some dynamics that favor the spread of viruses. We will then present some innovative tools for effective protection.
In line with forecasts, the 2025-2026 flu season has confirmed its criticality throughout the Italian territory. According to the most recent reports from the RespiVirNet integrated surveillance system of the Higher Institute of Health (ISS), the first week of January 2026 saw a significant incidence of acute respiratory infections, with 14.1 cases per 1,000 assisted individuals. Despite a slight decrease compared to the Christmas period, experts have predicted a further rise corresponding with the return to work and school activities (e.g., reopening of schools and offices).
Investigations into circulating viruses show a predominance of type A influenza viruses, which represent the vast majority of cases. Sequencing studies reveal a notable presence of the A(H3N2) subtype, primarily the subclade K, followed by the A(H1N1)pdm09 subtype. As expected, the co-presence of different strains sustains the incidence and puts pressure on the healthcare system.
Furthermore, the geographical distribution of infections appears heterogeneous. In Campania (20.53 cases/1,000), Sicily (19.41 cases/1,000), and Marche (18.52 cases/1,000), for example, the situation is particularly complex, with a sharp increase in emergency room visits and hospitalizations for respiratory symptoms.
A significant aspect concerns severe cases: the majority of pneumonias treated in intensive care correspond to unvaccinated individuals. This highlights the great importance of flu vaccines, recommended by the Ministry of Health for high-risk groups (such as the elderly, chronically ill, and immunocompromised individuals), while adherence to annual campaigns remains relatively low.
Why Offices and Schools are the Main Flu Clusters
The transmission modes of respiratory viruses, such as the flu, SARS-CoV-2, and the common cold, also depend on environmental characteristics. Indoor spaces, especially those with high occupancy and poor ventilation, are ideal places for the accumulation of viruses in bioaerosols. Schools, universities, and offices, where people gather and interact constantly, prove to be true epidemic clusters.
The reopening of schools after annual breaks is a well-known amplification factor. Experts point out how the return to school of millions of students, teachers, and staff creates a massive context for viral transmission. Studies conducted on influenza, in particular, have shown that children form a significant reservoir for the virus, contributing to its spread in the community. The tripled incidence in the 0-4 age group, compared to the general population, is the most evident proof of this.
The scenario is similar in the workplace. Common tools (e.g., phones, mice, etc.), as well as shared surfaces (such as desks, switches, and handles), are vehicles for indirect transmission, as viral particles persist on them for hours or days. Interpersonal proximity, meetings in confined spaces, and HVAC systems without proper filtration further encourage infection risk.
Micro-droplets and the Persistence of Respiratory Viruses in Still Air
When an infected individual speaks, coughs, or sneezes, they also emit viral particles around them. These spread through space in the form of:
- Droplets: relatively large particles (diameter > 5-100 microns). Due to their weight, these settle within one or two meters, landing on nearby surfaces.
- Aerosols (or micro-droplets): much smaller particles (diameter < 5 microns), capable of remaining suspended for hours and settling more than two meters away. Their "staying" time in the air increases in poorly ventilated spaces.
Scientific research, such as studies performed on SARS-CoV-2, has highlighted that the virus can remain viable in bioaerosols for over 3 hours. Regardless of the peculiarities of each pathogen, this basic behavior remains valid for all respiratory viruses.
While relevant, interpersonal distancing is not enough to protect individuals from viruses dispersed in indoor air and/or deposited on surfaces. Furthermore, if an infected person remains in an indoor space, the viral concentration in the air increases over time, exposing others present to the risk of contagion.
The Limitations of Natural Ventilation During Cold Months
The primary recommendation for diluting viruses in bioaerosols is to open windows often, allowing for good natural ventilation. However, this can be inconvenient during winter months for the reasons described below.
- Heat Loss and Energy Costs: Opening windows in winter results in the loss of heat stored indoors, overloading heating devices and increasing utility bills.
- Discomfort and Health: Cold air drafts cause significant discomfort for occupants, leading to infrequent window opening. This is a critical aspect for work and educational spaces, where maintaining a pleasant temperature supports productivity.
- Inefficiency of the Practice: For optimal air exchange without excessive wall cooling, “shock ventilation” would be desirable. In other words, windows should be opened fully for at least 5 or 10 minutes, several times a day. However, this is often impractical as it is not always compatible with the comfort of all occupants. Keeping windows slightly open at all times, on the other hand, is both expensive and ineffective.
In this context, the need for alternative solutions arises, capable of ensuring
air healthiness without compromising environmental comfort or increasing costs.
From Passive Defense to Active Protection: The e4life Solution
Traditional biosecurity tools, such as distancing, face masks, and ventilation, are “passive” defense measures. They limit the chances of contagion but present some limits, as mentioned above. Technological progress, on the other hand, has paved the way for active protection strategies. In their various forms, these allow for action against viral agents accumulating in environments, inactivating them. Below are some solutions available today.
- HEPA Filters (High Efficiency Particulate Air): an H14 rated HEPA filter can capture 99.995% of suspended particles down to 0.1-0.2 microns. While captured, viruses in bioaerosols are not inactivated. Furthermore, these filters require periodic replacement.
- UV-C Rays: due to its wavelength, ultraviolet radiation is harmful to the genetic material of viruses and can therefore inactivate these pathogens. However, it is a dangerous method for humans if direct exposure occurs.
- Photocatalytic Oxidation (PCO): this technology uses a catalyst (titanium dioxide, TiO₂) and UV light to generate hydroxyl radicals. These are damaging to pathogens dispersed in the environment. While interesting, PCO leads to harmful by-products for humans, such as formaldehyde.
In the field of active protection lies the technology of e4life, which originated during the COVID-19 pandemic. Based on a different principle than those mentioned above, it boasts requirements for efficacy, safety, and convenience.
How Resonance Technology Reduces Viral Load in Real Time
e4life devices work with e4shield™ technology, which uses the SRET (Structure Resonant Energy Transfer) phenomenon to inactivate viruses. Here is a basic explanation of the mechanism:
- The devices emit an electromagnetic field at low intensity and specific frequencies, targeted to interact with respiratory viruses;
- These electromagnetic waves, which are harmless to the environment’s occupants, hit the outer envelope of the viruses, inducing a “vibrational resonance” within it;
- This phenomenon results in mechanical stress, and therefore in irreversible structural damage to the viral particle, which is then inactivated.
Here are the advantages of the technology, point by point.
- User Safety: The radiation emitted by the devices is characterized by low power, which is lower, for example, than that of a Wi-Fi network. Importantly, the devices hold CE and SAR (Specific Absorption Rate) certifications,
guaranteeing safe use for people and animals.
- Proven Efficacy: Rigorous tests conducted by prestigious institutes (Celio Military Hospital, ViroStatics, University of Milan, University of Genoa) have shown a viral inactivation capacity exceeding 90%. Pathogens considered include SARS-CoV-2 (and variants) and seasonal flu viruses.
- Continuous Action: The neutralizing action of the devices is instantaneous and continuous, covering up to 50 square meters in the environmental version.
- No Harmful By-products: This technology is distinguished by the absence of harmful by-products, such as the aforementioned formaldehyde. Furthermore, it does not require filters to be replaced or additional chemical components to function.
- “One Health” Approach: In developing the technology, e4life followed the “One Health” philosophy, recognizing the interconnection between living beings and the environment and prioritizing collective health in its entirety.
- Paradigm Shift: e4shield™ serves as an active solution to infection risk, where the viral threat is neutralized by a “biosecurity cloud” acting in real time.
Frequently Asked Questions (FAQ)
When is the flu peak usually reached in Italy?
Usually, the epidemic peak in our country is observed between late January and early February. However, the 2025-2026 flu season was distinguished by significant viral circulation as early as the beginning of December.
How can I reduce contagion in the office without losing heat?
An effective method combines frequent air exchange with the application of active protection measures. e4life devices, for example, continuously neutralize viruses in bioaerosols, making frequent window opening less critical.
Is e4life technology effective against all flu strains?
Yes, e4shield™ technology proves successful against various respiratory viruses and their variants. Its operating principle is physical rather than biological (unlike vaccines, which require periodic updates).
